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 32 
 33 
SUMMARY 34 
The second messenger cyclic-di-AMP plays important roles in cell growth, virulence, cell wall 35 
homeostasis, potassium transport and is known to affects resistance to antibiotics, heat and 36 
osmotic stress. Most Firmicutes contain only one c-di-AMP synthesizing diadenylate cyclase 37 
(CdaA) and apart from the positively regulating CdaR proteinhowever, little is known about 38 
signals and effectors controlling CdaA activity.  In this study, a genetic screening method was 39 
used to identify components which affect the c-di-AMP level in Lactococcus.  We characterised 40 
suppressor mutations that restored osmoresistance to spontaneous c-di-AMP phosphodiesterase 41 
gdpP mutants which contain high c-di-AMP levels. Functionally Ddestructive and restorative 42 
mutations were identified in the cdaA and gdpP genes, respectively, which lead to lower c-di-43 
AMP levels.  A mutation was also identified in the phosphoglucosamine mutase encoding gene 44 
glmM which is commonly commonly located withinin the cdaA operon in bacteria.  The glmM 45 
I154F mutation resulted in a lowering of the c-di-AMP level and a reduction in the key 46 
peptidoglycan precursor UDP-N-acetylglucosamine in L. lactis. C-di-AMP synthesis by CdaA 47 
was shown to be inhibited by GlmM and more by GlmM
I154F
, while the GlmM
I154F
 variant was 48 
found to bind more strongly to CdaA than GlmMUsing Escherichia coli as a heterologous 49 
expression host, c-di-AMP synthesis by CdaA was shown to be reduced by GlmM and 50 
furthermore by the GlmM
I154F
 variant.  These findings identify GlmM as a c-di-AMP level 51 
modulating protein and provide a direct connection between c-di-AMP synthesis and 52 
peptidoglycan biosynthesis.   53 
 54 
 55 
INTRODUCTION 56 
Ubiquitous nucleotide second messengers including cAMP, cGMP, (p)ppGpp, c-di-GMP and c-57 
di-AMP have been shown to control a wide range of bacterial processes (Kalia et al., 2013). The 58 
recently discovered essential nucleotide c-di-AMP has been found in some Gram-negative and 59 
many Gram-positive bacteria and has been shown to control bacterial growth, cell wall 60 
homeostasis, potassium transport, antibiotic resistance, osmotolerance, cell lysis, metabolism and 61 
immunomodulation (Woodward et al., 2010; Corrigan et al., 2011; Luo and Helmann, 2012a; 62 
Pozzi et al., 2012; Smith et al., 2012; Bai et al., 2013; Mehne et al., 2013; Witte et al., 2013; Bai 63 
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et al., 2014; Sureka et al., 2014; Ye et al., 2014). Up until recently c-di-AMP was considered 64 
essential for cell viability, however work in Listeria monocytogenes has shown that c-di-AMP is 65 
not essential for growth in minimal media (Whiteley et al., 2015).  For optimal growth on 66 
nutrient rich media, however, Llevels of c-di-AMP need to be strictly controlled in the cell by 67 
modulation of expression and/or activity of c-di-AMP synthesis and degradation enzymes 68 
(Corrigan and Grundling, 2013). Most bacteria possess one diadenylate cyclase (DAC) enzyme 69 
(CdaA [also called YbbP and DacA]) (Romling, 2008; Corrigan and Grundling, 2013) while 70 
Bacillus subtilis has two additional DACs (CdaS [also called YojJ] and DisA) (Romling, 2008).  71 
DHH/DHHA1 domain containing phosphodiesterases (PDEs) such as membrane bound GdpP-72 
type (also called YybT or Pde1) and standalone PDEs carry out c-di-AMP hydrolysis (Bai et al., 73 
2013; Corrigan and Grundling, 2013). Recently another c-di-AMP phosphodiesterase (PgpH) of 74 
the HD-domain family has been identified in L.isteria monocytogenes (Huynh et al., 2015).  75 
Diadenylate cyclase activity of the DNA integrity scanning protein DisA has been shown to be 76 
negatively regulated by another DNA associated protein RadA (Zhang and He, 2013) while 77 
CdaS is regulated by its own N-terminal inhibitory domain (Mehne et al., 2014). The membrane 78 
bound CdaA protein has been shown to be positively regulated by the YbbR-domain containing 79 
protein CdaR through direct protein-protein interaction (Mehne et al., 2013). GdpP and PgpH 80 
activity is inhibited by the stringent response compound (p)ppGpp and it GdpP contains a 81 
possibly regulatory hemin binding PAS domain (Rao et al., 2010; Tan et al., 2013; Huynh et al., 82 
2015).  Expression of gdpP in B. subtilis is also transcriptionally regulated by σD (Luo and 83 
Helmann, 2012b).  Recent work has also identified cross-talk between c-di-AMP and (p)ppGpp 84 
signalling nucleotides with both high and low c-di-AMP levels triggering high (p)ppGpp (Liu et 85 
al., 2006; Corrigan et al., 2015; Whiteley et al., 2015).  Apart from these studies, little is known 86 
regarding stimuli which control the c-di-AMP level within a cell. In single DAC containing 87 
bacteria, c-di-AMP has been shown to be involved in cell wall homeostasis and osmotolerance 88 
and therefore stimuli related to these processes are likely to be involved.     89 
Modulation of signal transduction can occur by c-di-AMP binding to effector proteins 90 
and RNA molecules which then influence their activity. Effectors which bind c-di-AMP have 91 
been identified including the transcription factor DarR from Mycobacterium smegmatis (Zhang 92 
et al., 2013); the K
+
 transport gating protein KtrA, ion transporter CpaA and PII-like signal 93 
transduction protein PstA from Staphylococcus aureus (Corrigan et al., 2013); the ydaO 94 
riboswitch class in Actinobacteria, Bacillales, Clostridia and Cyanobacteria (Nelson et al., 95 
2013); and pyruvate carboxylase, CbpA, CbpB, NrdR, PstA and several other proteins which 96 
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may bind c-di-AMP indirectly in L. monocytogenes (Sureka et al., 2014). Crystal structures of 97 
pyruvate carboxylase (Sureka et al., 2014), PII-like signal transduction proteins (Campeotto et 98 
al., 2015; Choi et al., 2015; Gundlach et al., 2015a; Muller et al., 2015), RCK domains of KtrA 99 
and CpaA (Chin et al., 2015; Kim et al., 2015) and the ydaO riboswitch (Gao and Serganov, 100 
2014; Jones and Ferre-D'Amare, 2014; Ren and Patel, 2014) have provided insights into c-di-101 
AMP binding sites.  The first structure of a CdaA-type DAC has also been recently reported 102 
(Rosenberg et al., 2015).  Many of these c-di-AMP targets however are yet to be thoroughly 103 
characterized and thus their roles in c-di-AMP controlled phenotypes are still to be elucidated. 104 
Previous research has identified osmosensitive phenotypes for gdpP mutants of L. lactis 105 
and S. aureus (Smith et al., 2012; Corrigan et al., 2013). In this study we used a genetic 106 
screening approach to identify proteins involved in controlling the c-di-AMP level and thus 107 
osmotolerance in L. lactis. The roles of the c-di-AMP synthesis and hydrolysis enzymes (CdaA 108 
and GdpP) were confirmed, while the broadly conserved cell wall biosynthesis enzyme GlmM 109 
was identified as a new c-di-AMP level modulator. The results presented identify a connection 110 
between c-di-AMP signalling and cell wall biosynthesis pathways.  111 
 112 
RESULTS 113 
Mutations in the diadenylate cyclase encoding gene (cdaA) restore osmoresistance in gdpP 114 
defective mutants 115 
Previous studies in our laboratory identified a role of the c-di-AMP phosphodiesterase GdpP in 116 
osmotolerance in two independent strains of L. lactis (Smith et al., 2012). During this work we 117 
noticed that upon plating of spontaneous osmosensitive gdpP mutants (OS strains) on high salt 118 
containing agar, the presence of healthy looking colonies at low frequency (~1 in 10,000 to 119 
100,000, as seen in Fig.ure 1, panels A and C in (Smith et al., 2012)). The OS strains used here 120 
contain either a single nucleotide changes (OS1 and OS3 contain gdpPA573D and gdpPE472Stop, 121 
respectively) or a single nucleotide insertion (OS2 contains gdpPK122Stop) (Smith et al., 2012). We 122 
hypothesised that the reason for osmosensitivity of gdpP mutant strains was due to a high 123 
intracellular c-di-AMP level and that osmoresistant suppressor mutants (OR strains) which could 124 
grow on high salt agar would contain mutations which would lower the c-di-AMP level.  Two 125 
colonies derived from OS1 growing on high salt agar (named OR1 and OR2 [Table S1]) were 126 
picked and confirmed to be stably osmoresistant (Fig. 1A). In fact OR2 became dependent upon 127 
high osmotic conditions for efficient growth (Fig. 1A). To identify the mutation(s) in OR1 and 128 
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OR2, whole genome sequencing was performed. Only one common gene was mutated in both 129 
OR1 and OR2 which was llmg_0448 (or herein named cdaA) (Table 1). This gene encodes a 130 
diadenylate cyclase (DAC) which has homology to CdaA (also termed DacA and YbbP). The 131 
mutations in cdaA are likely to cause abnormal abolished protein expression (CdaA
E11frameshift
 in 132 
OR1) or reduced activity (CdaA
M136I 
in OR2) of the enzymeCdaA resulting in a lowering of the 133 
intracellular c-di-AMP level. Indeed intracellular c-di-AMP levels were significantly lower in the 134 
OR1 and OR2 strains than in the parent OS1, which contains a gdpP mutation, though not as low 135 
as for wild-type MG1363 (below detection limit)  (Fig. 1B). CdaA in L. lactis is the only protein 136 
containing a DAC domain. These results show that the c-di-AMP level influences salt resistance 137 
in L. lactis and can be altered through mutation in the DACc-di-AMP synthesis  (CdaA) or and 138 
PDEdegradation enzyme (GdpP).  139 
To identify more sites within CdaA which are important for c-di-AMP synthesis and also 140 
other genes which may affect the c-di-AMP level and thus osmotolerance, 158 additional salt 141 
resistant suppressor mutants from several different gdpP mutant backgrounds (OS1 [n=42], OS2 142 
[n=112] and OS3 [n=4] [Table S1]) were obtained and characterized. The cdaA gene was 143 
amplified by PCR and sequenced and 66 independent cdaA mutations were identified in total 144 
(Fig. 2 and Fig. S1). These mutations resulted in amino acid changes, frameshift mutations, a 145 
start codon change (from TTG to TTA) and the insertion of an IS905 element 12-bp upstream of 146 
cdaA. Changes were found at the extracellular N-terminal region, both in and between the three 147 
transmembrane spanning domains and also in the DAC enzymatic domain (Fig. 2), and therefore 148 
may affect protein expression, signal sensing, oligomerization and/or enzymatic activity. A vast 149 
majority of the mutations resulted inresulted in a a D123Y change in CdaA, suggesting a 150 
significant proportion of sibling mutants were present in our culture stocks.  CdaA mutations 151 
were obtained in two independent gdpP mutants derived from both MG1363 (OS1 and OS2) and 152 
an industrial L. lactis strain background (OS3).  Salt resistant industrial strain derivatives OR3 153 
and OR4 which contained CdaA
T50K
 and CdaA
A195D
 changes, respectively which resulted in the 154 
same salt resistant phenotype and, had significantly reduced  reduction in c-di-AMP levels 155 
compared to their parent OS3 (Fig. 1C & 1D).  Out of all the salt resistant suppressor mutants 156 
obtained, only five mutants possessed no changes in the cdaA gene. Another way the cell might 157 
reduce the c-di-AMP level is through restoration of PDE activity.  Therefore the gdpP gene was 158 
sequenced in the five mutants and in four (derived from OS1) new mutations were observed. The 159 
OS1 parent contains an A573D change in GdpP from wild-type MG1363 (Smith et al., 2012). 160 
The four osmoresistant suppressor mutants either had reverted back to alanine at this position or 161 
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a similar residue (glycine) thereby likely restoring c-di-AMP PDE activity. The final 162 
characterized osmoresistant suppressor mutant (OR5) still possessed the same gdpP mutation 163 
present in its parent OS2 (K122Stop) and therefore was predicted to still have no or low PDE 164 
activity. 165 
 166 
GlmM affects osmoresistance as well as peptidoglycan precursor and c-di-AMP levels 167 
The osmoresistant mutant (OR5) which contained unaltered cdaA and gdpP gene sequences as 168 
its osmosensitive parent strain (OS2) was confirmed to be salt resistant (Fig. 3A).  Interestingly 169 
OR5 had a significantly reduced levels of c-di-AMP (Fig. 3B), which were similarly low aswas 170 
similar to that observed for cdaA mutants OR1 and OR2 (Fig. 1B). Whole genome sequencing 171 
was carried out on this strain and its parent (OS2), and only one single nucleotide difference 172 
(A→T) was identified. This change was in the glmM (femD) gene and was confirmed by Sanger 173 
sequencing as causing an I154F amino acid change in the encoded protein. GlmM is the 174 
phosphoglucosamine mutase enzyme responsible for interconversion of glucosamine-6-175 
phosphate to glucosamine-1-phosphate and forms an early part of the pathway leading to the 176 
biosynthesis of cell wall peptidoglycan and other cell wall polymers including the cell wall 177 
pellicle produced by L. lactis (Fig. 3C) (Chapot-Chartier et al., 2010). The glmM gene is present 178 
in the same operon as the cdaA gene in L. lactis (Fig. 3D), a genetic arrangement that is highly 179 
conserved in almost all Firmicutes (Bai et al., 2013; Corrigan and Grundling, 2013; Dengler et 180 
al., 2013; Mehne et al., 2013). To determine if cell wall biosynthesis precursor levels are 181 
affected by changes in the intracellular c-di-AMP level and by the GlmM I154F mutation, we 182 
measured intracellular UDP-N-acetylglucosamine (UDP-NAG) levels. The level of UDP-NAG 183 
was around 3-fold higher in the high c-di-AMP gdpP mutant strain (OS2) compared to wild-type 184 
and was reduced to below wild-type levels as a result of the glmM mutation in OR5 (Fig. 3E). 185 
This result demonstrates that c-di-AMP affects the level of cell wall biosynthesis precursor and 186 
that the I154F GlmM mutation leads to reduced peptidoglycan precursor biosynthesis. 187 
Interestingly the low c-di-AMP level observed in the glmM mutant strain also suggests that cell 188 
wall precursor biosynthesis activity can also affect the c-di-AMP level in the cell.  189 
Previous work has identified the involvement of c-di-AMP in cell lysis (Luo and 190 
Helmann, 2012a; Witte et al., 2013). We therefore investigated if the glmM mutation would also 191 
alter autolysis activity.  Like that found in B. subtilis and L. monocytogenes, different most OR 192 
cdaA mutant strains lysed significantly faster than their parent (OSR2) (Fig. 4).  The glmM 193 
mutant (OR5) lysed similarly to the strains that contained cdaA mutations and faster than OS2 194 
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(Fig. 4). The wild-type exhibited a moderate slower autolytic rate than OS2, in between the OS 195 
and OR derivatives. These results collectively provide support for the role of c-di-AMP and 196 
glmM in cell wall stability.  197 
The product of the gene located between the cdaA and glmM in L. lactis MG1363 (Fig. 198 
3D) has significant homology to the CdaR protein from B. subtilis whichand has been identified 199 
as a positive regulator of diadenylate cyclase activity of CdaA (Fig. 3D) (Mehne et al., 2013).  In 200 
B. subtilis, L. monocytogenes and S. aureus, CdaR contains several YbbR domains (pfam07949) 201 
and is also encoded by a single gene located between cdaA and glmM. In MG1363 there appears 202 
to have been a single nucleotide deletion in a single ancestral cdaR gene resulting in a premature 203 
stop codon and is annotated as a pseudogene in the MG1363 Genbank entry (NC_009004.1).  204 
This sequence deletion was confirmed by Sanger sequencing in MG1363.  It is possible that this 205 
pseudogene could express two open reading frames (previously denoted in NC_009004.1 as 206 
llmg_0449 and llmg_0450), however the YbbR domain would not be linked to the N-terminal 207 
transmembrane domain and thus not exposed on the extracellular side of the membrane like other 208 
CdaR proteins.  Investigation of other available Lactococcus spp. genomes (strains SK11, 209 
IL1403, A76, TIFN3, TIFN6, UC509.9, A12, KF147, IO-1, CNCMI-1631 and CV56) and four 210 
industrially used Lactococcus in our culture collection revealed a full length ~320 aa CdaR 211 
encoding gene in all cases, therefore suggesting that the mutated CdaR in MG1363 is unusual for 212 
Lactococcus.. Therefore in MG1363, the YbbR domains which are encoded by the downstream 213 
potential open reading frame within cdaR' (llmg_0450) are separated from the N-terminal 214 
transmembrane domains and therefore likely to not be anchored to the cytoplasmic membrane 215 
and possibly not even expressed due to the absence of an efficient ribosome binding site. 216 
 217 
GlmM down-regulates c-di-AMP synthesis by CdaA and the GlmM
I154F
 variant has greater 218 
inhibitory activity. 219 
To determine evaluate the effect of GlmM and GlmM
I154F
 in controlling CdaA activity more 220 
directly, we expressed different combinations of L. lactis cdaA operon genes in E. coli which is 221 
known to not produce c-di-AMP (Corrigan et al., 2011; Mehne et al., 2013) (Fig. 5A).  By 222 
comparing c-di-AMP levels in E. coli containing the complete cdaAR'-glmM operon, iIt was 223 
found that E. coli expressing the the cdaAR'-glmMI154F variant operon led had to a 5-fold lower 224 
c-di-AMP concentration compared to that found with thefor E. coli expressing the wild-type 225 
cdaAR'-glmM operon (Fig. 5A & 5B).  This suggests that the I154F mutation in GlmM results in 226 
inhibition of CdaA activity and is in agreement with that found in L. lactis where the glmMI154F
  
227 
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mutation caused a lowering of the c-di-AMP level (Fig. 3B).  To determine the effect of wild-228 
type GlmM on CdaA activity, we compared c-di-AMP levels in E. coli containing the cdaAR'-229 
glmM and cdaAR' only operons and found that the presence of GlmM resulted in a 19-fold 230 
reduction in c-di-AMP level (Fig. 5A & 5B). Combined these resultsThis demonstrates a general 231 
inhibitory effect of GlmM on CdaA-mediated c-di-AMP synthesis and that the I154F mutation in 232 
GlmM enhances CdaA inhibition.   233 
To extend these findings further we expressed combinations of cdaA, cdaR and glmM 234 
genes from another Gram-positive bacterium (S. aureus NCTC 8325) in E. coli and measured c-235 
di-AMP levels (Fig. 5B).  In agreement with that above, S. aureus GlmM was found to reduce c-236 
di-AMP levels (Fig. 5B).  Comparison of c-di-AMP levels in E. coli expressing S. aureus CdaA 237 
and CdaAR also suggests that CdaR inhibits CdaA activity.  These results suggest that GlmM 238 
and CdaR are likely regulators of CdaA activity in a broad range of bacteria. 239 
 240 
Global protein analysis reveals c-di-AMP affects the expression of the glycine-betaine 241 
transporter and a penicillin binding proteinThe GlmM
I154F
 variant binds more strongly to 242 
CdaA than GlmM. 243 
C-di-AMP is expected to mediate its effects on cells by affecting gene expression or enzyme 244 
activity through binding of RNA (Nelson et al., 2013) or effector proteins (Corrigan et al., 2013). 245 
To determine the effects of elevated c-di-AMP on protein expression and to further explore how 246 
c-di-AMP controls cellular processes we compared the proteomes of wild-type MG1363 and 247 
OS2 using SWATH-MS (Gillet et al., 2012). Whole genome sequencing of the OS2 mutant in 248 
this study revealed only one single nucleotide polymorphism when compared to wild-type. This 249 
was a thymine insertion which causes a K122Stop change in the GdpP previously reported 250 
(Smith et al., 2012), thus making it a suitable gdpP mutant for this experiment. Using a 2-fold 251 
cut-off, 14 proteins were up-regulated and 16 proteins were down-regulated in the gdpP mutant 252 
compared to the wild-type (Table 2).  We hypothesized that the reason GlmM
I154F
 inhibits c-di-253 
AMP synthesis by CdaA more than wild type GlmM is due to a stronger interaction between the 254 
two proteins.  We examined the binding between CdaA and GlmM or GlmM
I154F
 using a 255 
bacterial two-hybrid system.  Following measurement of β-galactosidase activities, a direct 256 
interaction was found between CdaA and GlmM while a significantly stronger interaction 257 
between GlmM
I154F
 and CdaA was observed (Fig. 6).  The higher binding affinity of GlmM
I154F
 258 
for CdaA provides a possible explanation for why this variant protein has greater CdaA 259 
inhibitory activity and why OS5 contains lower c-di-AMP levels.   260 
Formatted: Indent: First line:  1.27
cm
Formatted: Font: Italic
Formatted: Font: Italic
Formatted: Font: Italic
Formatted: Font: Italic
Formatted: Font: Italic
Formatted: Font: Italic
Formatted: Font: Italic
Formatted: Font: Italic
Formatted: Superscript
Formatted: Superscript
Formatted: Superscript
Formatted: Superscript
Formatted: Superscript
9 
 
Of particular relevance to osmotolerance, the glycine betaine transporter BusAB was identified 261 
in the proteome analysis as being downregulated 2.9-fold (Table 2). This ATP-binding cassette 262 
(ABC) type compatible solute transporter (BusAA-AB) has been identified in L. lactis as being a 263 
major contributor to osmotolerance and is regulated by the transcriptional repressor BusR 264 
(Romeo et al., 2003). Previous work in our lab has identified that the RNA transcript level of 265 
busAA is downregulated ~5-fold in a gdpP mutant strain Δ1816 (Smith et al., 2012) and we 266 
determine here that OS2 has a ~10-fold lower busAA transcript than wild-type (data not shown). 267 
This suggests that c-di-AMP levels affect the expression of the BusAA-AB genes at a 268 
transcriptional level.   269 
The most highly upregulated protein (18-fold) in OS2 was DacA which encodes a cell wall 270 
peptidoglycan D-alanyl-D-alanine carboxypeptidase (note: DacA from L. lactis should not be 271 
confused with DacA in other bacteria which is a diadenylate cyclase, othologous to CdaA). This 272 
low molecular weight penicillin binding protein (PBP) has been shown to cleave the last alanine 273 
from the interpeptide crossbridge to provide a substrate for peptide crosslinking and has also 274 
been shown to affect resistance to the cell wall acting antimicrobial peptide Lcn972 (Roces et al., 275 
2012).  An isogenic ΔdacA mutant was constructed in a wild-type MG1363 background and was 276 
found to be more resistant to penicillin G (zone of inhibition size was 37.1±0.1 mm for wild-type 277 
MG1363 and 29.8±0.4 mm for ΔdacA) confirming its role in peptidoglycan 278 
biosynthesis/maturation.  This is in contrast to what was expected however, as ΔgdpP mutants 279 
are resistant to β-lactams (Corrigan et al., 2011; Luo and Helmann, 2012; Smith et al., 2012; 280 
Witte et al., 2013), therefore suggesting that other aspects of c-di-AMP signalling play a role in 281 
antibiotic resistance in L. lactis. 282 
 283 
 284 
DISCUSSION 285 
Here we identify GlmM as a modulator of c-di-AMP synthesis through its regulation of 286 
CdaA activity.Using a suppressor screen to isolate mutants with reduced c-di-AMP levels in 287 
gdpP mutant backgrounds and subsequent genetic and biochemical studies, we identify GlmM as 288 
an important modulator of CdaA-mediated c-di-AMP synthesis (Fig. 6).  In turn, it is In 289 
additionfound that, it was found that the c-di-AMP level affects peptidoglycan precursor 290 
synthesis, thereby demonstrating a close interconnection between c-di-AMP and peptidoglycan 291 
synthesis pathways.  The broadly conserved clustering of glmM in the diadenylate cyclase cdaA 292 
gene operon in Firmicutes hasd drawn speculation of a role of c-di-AMP in peptidoglycan 293 
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biosynthesis (Luo and Helmann, 2012a; Corrigan and Grundling, 2013; Mehne et al., 2013; 294 
Witte et al., 2013; Commichau et al., 2015).  How GlmM regulates CdaA activity is uncertain at 295 
present, however it appears likely to be through direct protein-protein interaction as 296 
demonstrated here.  In agreement with this, recent work by Gundlach et al (2015b) has 297 
demonstrated binding between B. subtilis CdaA and GlmM.  Coordinated activity of CdaA and 298 
GlmM is likely to occur and therefore play a role in various phenotypic changes observed in cells 299 
with altered c-di-AMP levels, such as cell lysis. A model likely to be broadly conserved based on 300 
our results and others involving CdaA and GlmM is shown (Fig. 7).  301 
It is possible that CdaA may be able to respond directly to GlmM activity through 302 
protein-protein interaction, since other clustered genes in DAC encoding operons have been 303 
shown to physically interact with the DAC and regulate c-di-AMP synthesis.  These include 304 
CdaR which positively regulates CdaA (Mehne et al., 2013) and RadA which negatively 305 
regulates DisA (Zhang and He, 2013). Alternatively, it may be an indirect effect with CdaA 306 
sensing cell wall precursor levels or peptidoglycan changes. Regardless of this, the essential 307 
nature of c-di-AMP may be due to its regulation of peptidoglycan precursor biosynthesisHere we 308 
identify GlmM as a modulator of c-di-AMP through its regulation of CdaA activity.  The variant 309 
GlmM
I154F
 identified in this study was found to inhibit CdaA activity and bind to CdaA more 310 
strongly than to reduce c-di-AMP levels in L. lactis and in E. coli expressing CdaAR' more so 311 
than wild-type GlmM.  The structure of GlmM location of the I154 site can be examined based 312 
on the known structure of the homologous GlmM from Bacillus anthracis (Mehra-Chaudhary et 313 
al., 2011).  Using SWISS-MODEL, the 154 site in GlmM is predicted to be exposed on thea 314 
surface region of opposite side of the protein away from the active site phosphate transferring 315 
serine at residue 101.  Interestingly the equivalent position of I154 in L. lactis GlmM is a 316 
phenylalanine (F) in S. aureus, B. subtilis and L. monocytogenes.  This suggests that the I154F 317 
mutation that occurred in the L. lactis GlmM doesn’t destroy activity of the enzyme.  It is 318 
possible that this region of the enzyme may be the point of contact between GlmM and CdaA, 319 
however more work is needed to determine this., but may alter how it is regulated and how it 320 
regulates CdaA.  321 
The only other identified regulator of CdaA that has been identified to date is the 322 
membrane bound extracellular exposed CdaR (Mehne et al., 2013).  In the heterologous host E. 323 
coli, it was shown that B. subtilis CdaR positively regulated CdaA and binding between the two 324 
proteins has been confirmed (Mehne et al., 2013).  In contrast, recent work in L. monocytogenes 325 
has suggested that CdaR is a negative regulator of CdaA as a cdaR mutant contained a higher c-326 
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di-AMP level (Rismondo et al., 2015).  Like that found for B. subtilis, L. monocytogenes CdaR 327 
and CdaA directly interact (Rismondo et al., 2015).  Our findings comparing c-di-AMP levels in 328 
E. coli expressing various combinations of cdaA operon genes from S. aureus suggest that CdaR 329 
also negatively regulates CdaA activity in this system.   Despite these differences, which may be 330 
due to the experimental conditions employed, it is clear that CdaR is an important regulator of 331 
CdaA.  Although strain backgrounds and gdpP mutations are different, a ~3-fold higher level of 332 
c-di-AMP in OS1 compared to OS3 could perhaps be due to L. lactis MG1363 derivatives not 333 
carrying a functional negative regulator CdaR as mentioned above.  In B. subtilis another DAC 334 
(Mehne et al., 2014)(DisA) is regulated by RadA (Zhang and He, 2013), suggesting that DAC 335 
enzymes likely operate as complexes with other proteins which regulate their activity and thus c-336 
di-AMP levels.   337 
 338 
. 339 
The vast majority of mutations restoring osmoresistance in gdpP mutants were affected in 340 
the CdaA enzyme thus providing an excellent inverse correlation between c-di-AMP level and 341 
osmoresistance. Numerous single amino acid altering suppressor mutations were identified in 342 
regions in CdaA outside of the DAC domain including within and between the three N-terminal 343 
transmembrane domains. It is possible that the changes may affect CdaA activity by affecting 344 
dimerisation which has been shown recently for L. monocytogenes CdaA (Rosenberg et al., 345 
2015), interaction with the CdaR or GlmM regulatory proteins or sensing of cell envelope or 346 
external stimuli. Synthesis of c-di-AMP has been found to be essential in several Gram-positive 347 
bacteria (Luo and Helmann, 2012a; Mehne et al., 2013) including L. monocytogenes, S. aureus 348 
and Streptococcus pneumoniae, where deletion of their single DAC gene is not possible when 349 
cultured on rich media (Song et al., 2005; Chaudhuri et al., 2009; Woodward et al., 2010).  350 
Recent work has however identified that CdaA and thus c-di-AMP is not essential in L. 351 
monocytogenes when cells are cultured on minimal media or when suppressor mutations 352 
affecting (p)ppGpp levels or peptide transport exist (Whiteley et al., 2015).  Since we were using 353 
rich media for our suppressor selection experiment, Wwe were surprised therefore to see 354 
frameshift mutations in the cdaA gene in osmoresistant suppressor mutants upstream of the DAC 355 
domain encoding region of cdaA, as this would be predicted to generate a cell devoid of DAC 356 
activity. However the location of an alternative ATG start codon (residue 136) just inside the 357 
start of the DAC domain could potentially allow expression of an N-terminally truncated enzyme 358 
(Fig. 2). In agreement with this, a low but detectable level of c-di-AMP was found in the OR1 359 
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mutant which has a frameshift mutation early in the gene (codon 11). Due to destructive 360 
background mutations in gdpP in the osmoresistant suppressor mutants, low levels of c-di-AMP 361 
are predicted to be more stable as the cell is likely devoid of significant c-di-AMP 362 
phosphodiesterase activity.  It is also plausible that cdaA naturally encodes two variants, one of 363 
which is the full length membrane bound version and the other may begin with M136 and be 364 
devoid of the N-terminal transmembrane domains.  Interestingly, this methionine is conserved in 365 
most CdaA proteins in other bacteria (Fig. S1). 366 
Suppressor mutations in cdaA have recently been identified in a B. subtilis strain lacking 367 
both GdpP and PgpH phosphodiesterases that underwent lysis on agar plates (Gundlach et al., 368 
2015b).   Overall c-di-AMP levels within the mutants however did not change, leading the 369 
authors to speculate that local pools of CdaA controlled c-di-AMP exist within the cell 370 
(Gundlach et al., 2015b).  Our findings of significantly lower c-di-AMP levels within L. lactis 371 
cdaA osmoresistant suppressor mutants perhaps reflect a more simple bacterium where only one 372 
DAC is present.  In addition to this, the relatively high c-di-AMP levels we observed in the L. 373 
lactis gdpP mutant, which were for example 80-fold higher than the cdaA suppressor mutant 374 
OR1, is possibly reflective of L. lactis lacking a PgpH phosphodiesterase (Huynh et al., 2015).  375 
Similarly the gdpP mutant of S. aureus, which also lacks PgpH(Huynh et al., 2015b), has ~15-376 
fold higher c-di-AMP than wild-type (Corrigan et al., 2011).  Evidence is mounting showing that 377 
growth conditions can alter the importance of different enzymes in their regulation of c-di-AMP 378 
levels, including nitrogen source (Gundlach et al., 2015b) and growth in media or host cells 379 
(Huynh et al., 2015) and it is likely that additional yet to be discovered enzymes exist which can 380 
regulate c-di-AMP under certain environmental conditions.      (Huynh et al., 2015) 381 
  382 
The role of c-di-AMP in cell wall homeostasis has been established based on several 383 
findings from several laboratories. It has been found in different bacteria that there is a direct 384 
correlation between resistance to cell wall acting antibiotics and c-di-AMP level (Corrigan et al., 385 
2011; Luo and Helmann, 2012a; Smith et al., 2012; Kaplan Zeevi et al., 2013; Witte et al., 386 
2013).  S. aureus gdpP mutants have increased peptidoglycan cross-linking (Corrigan et al., 387 
2011) and cCells with low c-di-AMP have been found to exhibit a lysis phenotype which can be 388 
stabilized by high osmoticNaCl conditions or Mg
2+
 (Luo and Helmann, 2012a; Witte et al., 389 
2013; Rismondo et al., 2015). In agreement with this, Wwe observed that many cdaA suppressor 390 
mutants exhibited growth defects on normal agar which could was be restored upon addition of 391 
salt, and also differences and also changes in autolysis rates in for strainscells with different c-di-392 
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AMP levels. Mutation in gdpP has been found to lead to increased peptidoglycan cross-linking 393 
in S. aureus (Corrigan et al., 2011) and in agreement with this we found that the PBP (DacA) is 394 
highly upregulated in a gdpP mutant and its inactivation affects penicillin resistance. DacA in L. 395 
lactis is a D-Ala-D-Ala-carboxypeptidase which cleaves peptidoglycan pentapeptide side chains 396 
to form tetrapeptide side chains (Roces et al., 2012). Spontaneous Lactococcus mutants with 397 
resistance to the bacteriocin Lcn972 were found to have lower levels of pentapeptide side chains 398 
and were sensitive to penicillin and lysozyme further suggesting an important role for DacA in 399 
peptidoglycan maturation and cell wall acting antimicrobial resistance (Roces et al., 2012). 400 
DacA is homologous to PBP3 from S. pneumoniae, DacA (PBP5) of B. subtilis and PBP4 of S. 401 
aureus and its role in trimming the last residue in the peptide side chain likely reduces the 402 
availability of donors for the transpeptidation reaction, thus regulating the degree of 403 
peptidoglycan crosslinking (Morlot et al., 2004).  In a recent study of S. aureus, PBP4 was found 404 
to be transcriptionally upregulated 2.7-fold in a gdpP mutant (Corrigan et al., 2015).  Further 405 
work exploring how c-di-AMP regulates DacA/PBP4 levels and what role this PBP plays in β-406 
lactam resistance is of interest to allow understanding of how c-di-AMP level changes lead to 407 
resistance to several different cell wall acting antibiotic classes (Luo and Helmann, 2012) .   408 
Here we identify GlmM as a modulator of c-di-AMP through its regulation of CdaA 409 
activity.  The variant GlmM
I154F
 was found to reduce c-di-AMP levels in L. lactis and in E. coli 410 
expressing CdaAR' more so than wild-type GlmM.  The structure of GlmM can be examined 411 
based on the known structure of the homologous GlmM from Bacillus anthracis (Mehra-412 
Chaudhary et al., 2011).  Using SWISS-MODEL, the 154 site in GlmM is predicted to be 413 
exposed on the surface of opposite side of the protein away from the active site phosphate 414 
transferring serine at residue 101.  Interestingly the equivalent position of I154 in L. lactis is a 415 
phenylalanine (F) in S. aureus, B. subtilis and L. monocytogenes.  This suggests that the I154F 416 
mutation that occurred in the L. lactis GlmM doesn’t destroy activity of the enzyme, but may 417 
alter how it is regulated and how it regulates CdaA. 418 
Comparison of the proteome of wild-type L. lactis to the gdpP mutant OS2 revealed 30 419 
proteins with a >2-fold difference in expression.  The glycine-betaine transporter BusAB was 420 
downregulated in the L. lactis gdpP mutant.  Another major function of c-di-AMP that has been 421 
identified is in the control of osmotolerance. Appropriate turgor pressure needs to be strictly 422 
controlled in bacteria by regulation of the accumulation of osmolytes including ions such as K
+
 423 
and compatible solutes such as glycine-betaine (Kempf and Bremer, 1998). Recent work has 424 
identified the K
+
 transport gating component KtrA as a c-di-AMP effector which affects 425 
Field Code Changed
14 
 
osmoresistance by regulating K
+
 transport in a c-di-AMP dependent manner (Corrigan et al., 426 
2013; Bai et al., 2014). Additionally the riboswitch ydaO which regulates the expression of a 427 
broad range of genes, including osmoprotection genes such as those encoding K
+
 and compatible 428 
solute transporters, has been shown to bind c-di-AMP (Nelson et al., 2013).  In L. lactis we have 429 
previously shown that the glycine-betaine transporter BusAA-AB is downregulated 5-fold in a 430 
gdpP mutant suggesting it may be a reason for the osmosensitive phenotype in this strain (Smith 431 
et al., 2012).  Interestingly numerous destructive mutations were identified in the GbuABC 432 
glycine-betaine transporter genes in c-di-AMP deficient suppressor mutants of L. monocytogenes 433 
(Whiteley et al., 2015) suggesting that high levels of intracellular glycine-betaine is detrimental 434 
to growth.  We hypothesise that K
+
 and glycine-betaine transporters are closed or not expressed, 435 
respectively, in cells with high c-di-AMP and are open or overexpressed, respectively, in cells 436 
with low c-di-AMP.  This would explain why high c-di-AMP cells are osmosensitive and low c-437 
di-AMP cells are osmoresistant or even become dependent upon high osmolarity for normal 438 
growth, as we found in the current study.  Further exploration of the role of c-di-AMP in 439 
osmoregulation is required to confirm this model and studies are needed to elucidate other 440 
important and possibly interrelated roles this signalling molecule plays within the cell. In 441 
contrast to our findings, in a microarray experiment performed with a gdpP mutant of L. 442 
monocytogenes, expression of the homologous osmolyte transporter (OpuCA encoded by 443 
lmo1428) was found to be upregulated 2.2-fold (Witte et al., 2013).  Only slightly increased 444 
levels of c-di-AMP were observed in the supernatant of this mutant therefore it is possible that 445 
the c-di-AMP level is not high enough to trigger downregulation of this osmolyte transporter.  446 
Whether c-di-AMP affects BusAA-AB expression directly or indirectly through possible effects 447 
on ion homeostasis remains to be determined. 448 
Several other differentially regulated proteins in our dataset have been reported in other 449 
studies examining c-di-AMP signalling.  The acetaldehyde-CoA/alcohol dehydrogenase AdhE 450 
and the oligopeptide binding protein transporter OppA were downregulated 3.6- and 2.5-fold, 451 
respectively in the L. lactis gdpP mutant.  AdhE was also transcriptionally downregulated 11-452 
fold in a gdpP mutant of S. aureus (Corrigan et al., 2015).  Interestingly, both AdhE (Lmo1634) 453 
and OppA were also identified recently in a chemical proteomics screen to identify c-di-AMP 454 
interacting proteins in L. monocytogenes (Sureka et al., 2014), indicating that this binding may 455 
affect protein levels.  Further work is needed to identify how c-di-AMP levels alter the 456 
expression of these proteins and importantly how this binding may influence the cell’s 457 
phenotype. 458 
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 461 
 462 
EXPERIMENTAL PROCEDURES 463 
Isolation of osmoresistant suppressor mutants from gdpP mutant strains OS1, OS2 and OS3 464 
L. lactis subsp. cremoris strains used in this study are shown in Table S1. Strain MG1363 and 465 
derivatives were cultured as described previously (Smith et al., 2012). Two independent 466 
MG1363 derivatives (OS1 and OS2) and an ASCC892185 derivative (OS3) contain mutations in 467 
the gdpP gene which were shown to be osmosensitive (Smith et al., 2012). To isolate 468 
osmoresistant suppressor mutants, cells were taken from different growth phases in broth (lag, 469 
mid-log and stationary phase), from colonies of agar plates and from frozen glycerol (40% final 470 
v/v) stocks and plated onto GM17 or LM17 containing an additional 0.2, 0.25 or 0.3 M sodium 471 
chloride. Following incubation for 2-3 days at 30°C, colonies were then re-streaked onto agar 472 
containing the same level of salt again to ensure purity before being subcultured in broth without 473 
added salt and frozen in 40% glycerol at -80°C. To confirm stable osmoresistance, cells were 474 
tested for growth on salt containing agar similarly to that described previously (Smith et al., 475 
2012). 476 
 477 
Whole-genome sequencing and mutation identification 478 
Whole genome sequencing of strains OS2, OR1, OR2 and OR5 was carried out using an 479 
Illumina HiSeq2000 instrument (Macrogen, South Korea). Trimming and mapping of 100-bp 480 
raw reads to the reference L. lactis MG1363 genome was performed using Geneious Pro 6.1.6 as 481 
described previously (Smith et al., 2012). Criteria for SNP identification were >100-fold 482 
coverage with >90% variant frequency as used previously (Linares et al., 2010; Smith et al., 483 
2012). In a few cases, SNPs which were called in one strain but not another (due to a slight 484 
greater than to having slightly lower than 90% variation frequency), were confirmed using a 485 
slightly lower threshold cut-off and manual inspection. SNPs in OS1 have been identified before 486 
(Smith et al., 2012) while SNPs in strains OS2, OR1, OR2 and OR5 are identified here from 487 
mapping using average read depths of 554-, 659-, 704- and 633-fold, respectively. SNPs in cdaA, 488 
gdpP and glmM were confirmed following PCR using GoTaq green (Qiagen) and Sanger 489 
sequencing (Macrogen, South Korea) using primers listed in Table S1. 490 
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 491 
Penicillin susceptibility test 492 
Susceptibility tests for penicillin were performed using a disk diffusion assay (Luo and Helmann, 493 
2012a) with slight modifications. A volume of 0.1 ml of the strain harvested in mid-log phase 494 
(OD600 ~ 0.6) was mixed with 5 ml of GM17 containing 0.75% agar and poured onto an agar 495 
base consisting of GM17 containing 1.5% agar (15ml). Sterile 8 mm diameter filter paper disks 496 
(Advantec, CA) were loaded with 20 μg penicillin G (Sigma-Aldrich, MO) and put on the agar. 497 
The diameter of each growth inhibition zone was measured after overnight incubation at 30°C. 498 
The difference between strains tested in triplicate was analyzed using the Student’s t-test. 499 
 500 
Extraction of c-di-AMP 501 
Overnight L. lactis cultures were diluted 1:100 into 30 ml GM17 or LM17 broth and incubated at 502 
30C till OD600~0.7 (mid-log phase). Cells were pelleted by centrifugation at 3,500 × g (Awel 503 
MF20, Awel International, France) for 5 min, and re-suspended in 1 ml ice-cold extraction buffer 504 
(40% methanol, 40% acetonitrile and 20% ddH2O in vol.). Fifty microliters of 2-,2-dideoxy-505 
cyclic diadenosine monophosphate (Biolog, Denmark) was added and used as an internal 506 
standard. Samples were mixed with 0.5 ml equivalent of 0.1 mm zirconia/silica beads and 507 
disrupted using a Mini-Beadbeater-16 (Biospec, USA) 3 times for 1 min each with 1 min cooling 508 
on ice in between. Glass beads were separated by centrifugation at 16,873 × g (Eppendorf, 509 
Germany) for 5 min. The supernatant was dried under liquid nitrogen before resuspended in 1ml 510 
ddH2O before being filtered (0.22 µm pore size). Levels of protein in a duplicate culture sample 511 
taken were determined following equivalent cell homogenisation using a Qubit Protein Assay Kit 512 
and Qubit 2.0 Fluorometer (Invitrogen, Life Technologies). 513 
 514 
Quantification of c-di-AMP 515 
C-di-AMP was detected and quantified by UPLC-coupled tandem mass spectrometry (UPLC-516 
MS/MS; Waters Corporation, Milford City, MA). The chromatographic separation was 517 
performed on an ACQUITY UPLC, using a C18-BEH 1.7µm x 2.1 x 100mm column. Eluent A 518 
consisted of 10 mM ammonium acetate in water and eluent B was methanol. Sample volume of 519 
10µl, with a flow rate of 0.3 ml/min. Eluent A (98%) was used from 0 to 1 min followed by a 520 
linear gradient from 98% to 50% of eluent A until 10 min.  The column was then washed with 521 
100% B for 4 mins, and then re-equilibrated with 98% A for 6 mins prior to re-injection. The 522 
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internal standard of 2-,2-dideoxy-c-di-AMP and commercial c-di-AMP (Biolog, Denmark) 523 
were used.  Analyte detection was performed on a Synapt G2-Si mass spectrometer equipped 524 
with an electrospray ionization source (Waters Corporation) using MRM transitions of the 525 
internal standard 627→216 and c-di-AMP 659→330 in positive ionization mode, using argon as 526 
collision gas. Detection of c-di-AMP was carried out with Mass Lynx software (Waters 527 
Corporation). 528 
 529 
Quantification of UDP-N-acetylglucosamine 530 
UDP-NAG was detected and quantified using a modified method (Marcellin et al., 2009). 531 
Cultures in mid-exponential growth phase were spun at 6,000 × g (Allegra X14, Coulter 532 
Beckman, USA) for 5 min, and the cell pellet was resuspended in ice cold 50% acetonitrile 533 
containing 50 nmol of azidothymidine (Sigma-Aldrich) as internal standard. Samples were lysed 534 
using 0.1 mm glass beads (Biospec, USA) using a Precellys 24 homogenizer equipped with a 535 
cryolys unit (Precellys, France) to maintain the temperature bellow 4°C. The supernatant was 536 
freeze dried and resuspended in 200 µL of MilliQ water. UDP-NAG was detected and quantified 537 
using LCMS. The mass spectrometer, an ABSciex 4000 QTRAP (ABSciex, Canada), was 538 
attached to a Dionex Ultimate 3000 liquid chromatography system (Dionex, USA). 539 
Chromatographic separation was achieved on a Gemini-NX C18 150×2.0 mm, 3 µm 110 Å 540 
particle column (Phenomenex, Germany) maintained at 55°C in the column oven as previously 541 
described (McDonald et al., 2014).  542 
 543 
Autolysis of L. lactis strains 544 
Overnight cultures of L. lactis MG1363, OS2, OR5 and several OR mutants with differing cdaA 545 
mutations were diluted 1/100 in 35 mL of fresh GM17 broth.  OD600 measurements using a 546 
spectrophotometer (Lovibond, Germany) were taken using 2 mL of culture regularly during the 547 
growth phase and then less regularly during lysis.  Before each sample was taken the culture was 548 
mixed by vortexing to ensure homogeneity of the cells.    549 
 550 
Expression of cdaA operon genes from L. lactis and S. aureus in E. coli. 551 
Genes from L. lactis MG1363 were synthesised and cloned into XhoI and PstI sites in pRSET-A 552 
downstream of the T7 promoter by Geneart (Life Technologies, Germany).  Gene names in 553 
MG1363 are named llmg_0448 (cdaA), llmg_0449 and llmg_0450 (cdaR') and llmg_0451 554 
(glmM).  The start codon for CdaA was changed from a TTG to an ATG in all the constructs to 555 
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improve expression.  For the glmMI154F mutant construct, a single nucleotide change was 556 
introduced which was identical to that found in L. lactis OR5.  Genes from S. aureus NCTC 557 
8325 were synthesised and cloned into XhoI and PstI sites in pRSET-A downstream of the T7 558 
promoter by Geneart (Life Technologies, Germany).  Gene names in NCTC 8325 are named 559 
SAOUHSC_02407 [cdaA], SAOUHSC_02406 [cdaR] and SAOUHSC_02405 [glmM]).   L. lactis 560 
gene Pplasmids were transformed into E. coli BL21 (DE3) (New England Biolabs, USA), while 561 
S. aureus gene plasmids were transformed in to E. coli T7 Express lysY/I
q
 (New England 562 
Biolabs, USA).  and Ggenes were expressed from OD600 ~0.5 (mid-log phase) with 1 mM 563 
isopropyl-B-D-thiogalactopyranoside (IPTG) for 3 hours at 37°C with shaking at 220 rpm.  Cells 564 
from 6 ml culture were harvested by centrifugation at 16,873 × g for 5 mins and c-di-AMP levels 565 
were determined as above for L. lactis.  Levels of protein in a duplicate culture sample taken 566 
were determined following equivalent cell homogenisation using a Qubit Protein Assay Kit and 567 
Qubit 2.0 Fluorometer (Invitrogen, Life Technologies). 568 
 569 
Bacterial two-hybrid system analysis of CdaA-GlmM interaction 570 
The bacterial adenylate cyclase two-hybrid system (Euromedex, France) allows evaluation of 571 
protein-protein interactions following co-expression of test proteins fused to T25 and T18 572 
subunits of the Bordetella pertussis adenylate cyclase.  If the proteins interact, T25 and T18 are 573 
brought together leading to cAMP synthesis and activation of the catabolite activator protein 574 
CAP resulting in increased expression of the lacZ reporter gene and β-galactosidase activity.  575 
PCR primers used to cloned genes into plasmids are shown in Table S1.  The L. lactis cdaA gene 576 
encoding a protein without the N-terminal transmembrane domains (αα 98-292) was cloned into 577 
PstI and KpnI digested pKNT25 in frame with the T25 cya gene fragment at the 3’ end.  The 578 
wild-type glmM and glmMI154F variant genes were cloned into PstI and KpnI digested pUT18C in 579 
frame with the T18 cya gene fragment at the 5’ end.  Plasmids, including empty pUT18C and 580 
pKNT25 and also positive control zip gene containing plasmids were transformed into E. coli 581 
DHP-1 and selection using kanamycin (50 µg/mL) and ampicillin (100 µg/mL) in Luria-Bertani 582 
(LB) agar. From this point onwards antibiotics were always included when growing these strains 583 
and incubation was always carried out at 29°C (Gloeckl et al., 2012).  β-galactosidase activity on 584 
agar was examined following spotting of mid-log phase (OD600 ~0.5) E. coli cultures grown in 585 
LB broth onto LB agar with IPTG (0.5 mM) and X-gal (40 µg/mL) and incubation for 16.5 hr at 586 
29°C.  Following this the plates were stored for 4 d at 4°C to allow colour development.  β-587 
galactosidase activity in broth was quantified from mid-log phase (OD600 ~0.5) E. coli cultures 588 
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grown in LB broth with IPTG (0.5 mM) and assayed according to the BACTH kit instructions 589 
(Euromedex, France) except chloroform was used to permeabilize cells instead of toluene.  590 
Enzymatic activity is presented as Miller units (Ref needed here XXXX).   591 
 592 
Proteome comparison of MG1363 and OS2 using SWATH MS 593 
Proteins were extracted from cell pellets obtained from triplicate mid-exponential phase cultures. 594 
Cells were lysed using glass beads for 5 minutes at 4,800 rpm using a Precellys 24 homogenizer 595 
equipped with a cryolys unit (Precellys, France) at 4°C. RNaseA and DNaseI (Thermo Scientific, 596 
USA) were added and incubated for 15 minutes at room temperature. The lysate was clarified at 597 
16,000 × g for 10 min at 0°C and the protein concentration in the supernatant was measured 598 
using the 2D Quant Kit (GE Healthcare, USA). Proteins (100 µg) were digested overnight with 599 
Trypsin Gold (Promega, USA) using FASP (Wisniewski et al., 2009) and analysed via Nano-LC 600 
MS/MS. The mass spectrometer (ABSciex TripleTof 5600, Canada), was equipped with a nano-601 
spray ESI sources operated in positive ion mode coupled to a Nano-LC (Shimadzu Prominence, 602 
Japan). Peptides were separated using a flow rate of 30 μl/min on a Vydac Everest C18 column 603 
(300 A, 5 μm, 150 mm × 150 μm) at a flow rate of 1 μl/min and a gradient of 10-60% mobile 604 
phase B over 90 min. Analyst Software was used for peak picking with a method searching for 605 
masses of 300 to 1800 Da. A SWATH reference library was generated from information-606 
dependent acquisition on a pooled sample containing 30 µg of proteins selecting for +2 to +4 607 
charges which exceeded 150 counts using Enhanced Resolution scans. The two most abundant 608 
ions in each of these scans (or with unknown charge) were subjected to MS/MS. Protein Pilot 609 
Software v 4.5 (ABSciex, Canada) and the Paragon Algorithm were used for peptide 610 
identification. The theoretical ions and peaks were matched using the tolerance used by the 611 
Paragon Algorithm search, based on information about the mass accuracy of the instrument 612 
chosen in the Paragon Method dialog box. Search parameters used were the same as specified 613 
previously (Marcellin et al., 2013). SWATH MS was used for protein quantification (Gillet et 614 
al., 2012). SWATH analyses scanned across m/z 350-1800 for 0.05 sec followed by high 615 
sensitivity DIA mode, using 26 m/z (1 m/z for window overlap) isolation windows for 0.1 sec, 616 
across m/z 400-1250. Collision energy for SWATH samples was automatically assigned based 617 
on m/z mass windows by Analyst. C18 ZipTips (Millipore, USA) were used to avoid overloading 618 
the detector and to ensure that equal amount of peptides (1 µg) were loaded in SWATH MS 619 
mode. Prior to MS analysis, samples were concentrated using a vacuum centrifuge to remove 620 
residual acetonitrile and resuspended in 99.5 µl of 0.1% formic acid (Mobile phase A). Each 621 
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sample was spiked with 0.5 µl of synthetic peptides in order to correct for retention time shifts 622 
between samples (HRM calibration kit from Biognosys, Switzerland). All IDA and SWATH 623 
samples were injected twice. Peak View (ABSciex, Canada) was used for peak selection.  624 
 625 
Contruction of a ΔdacA mutant 626 
Flanking regions either side of dacA (llmg_2560) were amplified and fused by splicing by 627 
overlap extension PCR (SOE-PCR) using primers listed in Table S1. These fragments were then 628 
cloned into suicide plasmid pRV300 (Leloup et al., 1997) to generate pRV300∆dacA which was 629 
transformed into the wt MG1363 using a standard method (Wells et al., 1993) and integrants 630 
were selected using 3 μg/ml erythromycin and confirmed by PCR. The vector was then excised 631 
from the chromosome by successive subculturing in fresh GM17 broth without erythromycin. 632 
Replica plating on GM17 agar with and without erythromycin allowed detection of the deletion 633 
mutant which was confirmed by PCR (Table S1). 634 
 635 
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 804 
Table 1. Polymorphisms identified in osmoresistant suppressor mutants OR1 and OR2 compared 805 
with the parent OS1 by whole genome sequencing. 806 
 807 
Strain Reference 
position  
Gene or region Gene function Nucleotide 
change  
Protein effect 
OR1 442839 llmg_0448 (cdaA) c-di-AMP synthase A deletion Frameshift from 
codon 11  
 1010850 142-bp upstream of busAA Glycine betaine 
transporter 
G → T Intergenic 
      
OR2 443214 llmg_0448 (cdaA) c-di-AMP synthase G → A M136I 
     
824826 16-bp upstream of uxuB Fructuronate reductase A → G Intergenic 
 808 
 809 
 810 
 811 
 812 
 813 
 814 
 815 
28 
 
 816 
 817 
 818 
Table 2. Proteome comparison of wild-type MG1363 and high c-di-AMP containing strain 819 
(OS2). Only proteins which had a >2.0 fold change and P<0.05 are presented and up-regulated 820 
proteins are shaded grey. 821 
GI # Protein^ 
 
Alternate 
protein 
name 
Putative function Fold change 
(OS2 vs wt) 
P-
value* 
125625313 Llmg_2560 DacA D-alanyl-D-alanine carboxypeptidase 18.2 0.01 
125624549 Llmg_1759  NADH-flavin reductase 12.2 0.04 
125625244 Llmg_2488 RuvA Holliday junction resolvasome, DNA-binding subunit 6.7 0.04 
125623715 Llmg_0871 Asd Aspartate-semialdehyde dehydrogenase 6.3 0.04 
125624459 Llmg_1660  TetR family transcriptional regulator 5.1 0.02 
125623296 Llmg_0429 SodA Superoxide dismutase 3.4 0.01 
125623422 Llmg_0557 PrfA Protein chain release factor A 3.3 0.03 
125625088 Llmg_2327 GlpF3 Glycerol uptake facilitator and related permeases 3.2 0.02 
125623323 Llmg_0456 PgmB β-phosphoglucomutase 2.8 0.00003 
125623774 Llmg_0933  RNA binding protein 2.7 0.001 
125623372 Llmg_0505 NifZ Cysteine sulfinate desulfinase/cysteine desulfurase and 
related enzymes 
2.4 0.005 
125624134 Llmg_1314  Uncharacterized FAD-dependent dehydrogenases 2.1 0.01 
125624935 Llmg_2164  Uncharacterized conserved protein 2.1 0.0009 
125623623 Llmg_0769  DivIVA cell division initiation protein 2.0 0.0005 
125624150 Llmg_1330  hypothetical protein 0.48 0.002 
125623375 Llmg_0508  Cysteine synthase 0.47 0.003 
125623558 Llmg_0702 PepO Predicted metalloendopeptidase 0.46 0.004 
125623934 Llmg_1103  hypothetical protein 0.44 0.003 
125623969 Llmg_1138 MtsA Manganese transporter (substrate binding protein) 0.43 0.0003 
125624260 Llmg_1452  Amino acid transporters 0.41 0.004 
125623557 Llmg_0701 OppA Peptide transport system (substrate binding protein) 0.40 0.002 
125623967 Llmg_1136 MtsB Manganese transporter (ATPase component) 0.40 0.002 
125622903 Llmg_0022 MtlA Phosphotransferase system, mannitol-specific IIBC 
component 
0.40 0.0001 
125625268 Llmg_2514  Universal stress protein family (UspA) 0.37 0.003 
125623880 Llmg_1049 BusAB Glycine betaine transporter (permease component) 0.35 0.00007 
125623830 Llmg_0993 HprT Hypoxanthine-guanine phosphoribosyltransferase 0.34 0.0003 
125623241 Llmg_0372 AsnB Asparagine synthase (glutamine-hydrolyzing) 0.29 0.0002 
125625190 Llmg_2432 AdhE bifunctional acetaldehyde-CoA/alcohol dehydrogenase 0.28 <0.00001 
29 
 
125625247 Llmg_2491 MutS Mismatch repair ATPase (MutS family) 0.13 0.008 
125624224 Llmg_1412 GuaC Guanosine 5'-monophosphate oxidoreductase 0.10 0.00004 
^from Genbank entry AM406671.1    *Statistical analysis of these data (three biological replicates per strain) was 822 
performed by fitting the data for each protein to a linear model using the R package Limma. Limma's empirical 823 
Bayes method was used to calculate a moderated t-statistic test for the contrast and proteins were classified as 824 
differentially expressed if the adjusted p-value (Benjamini-Hochberg) was lower than 0.05. 825 
 826 
FIGURE LEGENDS 827 
Figure 1.  828 
Osmoresistant suppressor mutants of L. lactis OS1 and OS3 have reduced c-di-AMP. (A) 829 
Comparison of growth of L. lactis MG1363 background strains on GM17 agar or GM17 agar + 830 
0.25 M NaCl following spotting of serial dilutions. (B) Levels of c-di-AMP in wt, OS1, OR1 and 831 
OR2 mutants from three biological replicates. (C) Comparison of growth of industrial L. lactis 832 
ASCC892185 background strains on LM17 agar or LM17 agar + 0.2 M NaCl following spotting 833 
of serial dilutions. (D) Levels of c-di-AMP in wt, OS3, OR3 and OR4 mutants from three 834 
biological replicates. Significant P<0.01 (**) and P<0.05 (*) results were determined using 835 
Tukey’s test. ND, none detected. 836 
 Figure 1.  837 
Osmoresistant suppressor mutants of OS1 have reduced c-di-AMP. (A) Comparison of growth of 838 
L. lactis MG1363 background strains on GM17 agar or GM17 agar + 0.25 M NaCl following 839 
spotting of serial dilutions. (B) Levels of c-di-AMP in wt, OS1, OR1 and OR2 mutants. (C) 840 
Comparison of growth of industrial L. lactis ASCC892185 background strains on LM17 agar or 841 
LM17 agar + 0.2 M NaCl following spotting of serial dilutions. (B) Levels of c-di-AMP in wt, 842 
OS3, OR3 and OR4 mutants. **, P<0.01 using Tukey’s test based on results from duplicate 843 
cultures. ND, none detected. 844 
 845 
Figure 2.  846 
Location of mutations in the CdaA protein in osmoresistant suppressor mutants. Red dots 847 
indicate amino acid changes and dark blue horizontal bars indicate frameshift mutations. The 848 
transmembrane domains are highlighted as thick yellow regions and the DAC domain is marked 849 
green. The DAC active site residues are highlighted in cyan.  850 
 Figure 2.  851 
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Location of mutations in the CdaA protein in osmoresistant suppressor mutants. Red dots 852 
indicate amino acid changes and dark blue horizontal bars indicate frameshift mutations. The 853 
transmembrane domains are highlighted as thick yellow regions and the intracellular DAC 854 
domain is marked green. The DAC active site residues are highlighted in cyan.  855 
 856 
Figure 3. 857 
Mutation of glmM affects salt resistance, c-di-AMP level and peptidoglycan precursor synthesis. 858 
(A) Comparison of growth of strains on GM17 agar or GM17 agar + 0.25 M NaCl following 859 
spotting of serial dilutions. (B) Levels of c-di-AMP in wt, OS2 and OR5 mutants from three 860 
biological replicates. (C) Early steps in the bacterial cell wall peptidoglycan biosynthesis 861 
pathway. (D) Location of the glmM (femD) gene in the same operon as cdaA and the frameshift 862 
mutated cdaR pseudogene (denoted as cdaR') in MG1363.  The GlmM I154F mutation in OR5 is 863 
shown with an arrow. (E) Levels of peptidoglycan precursor UDP-N-acetylglucosamine in 864 
strains from three biological replicates. Significant P<0.01 (**) and P<0.05 (*) results were 865 
determined using Tukey’s test. ND, none detected.  866 
 Figure 3. 867 
Mutation of the glmM gene affects salt resistance, the c-di-AMP level and peptidoglycan 868 
precursor synthesis. (A) Comparison of growth strains on GM17 agar or GM17 agar + 0.25 M 869 
NaCl following spotting of serial dilutions. (B) Levels of c-di-AMP in wt, OS2 and OR5 870 
mutants. **, P<0.01 using Tukey’s test based on duplicate cultures. ND, none detected. (C) Early 871 
steps in the bacterial cell wall peptidoglycan biosynthesis pathway. (D) Location of the glmM 872 
gene in the same operon as cdaA and the frameshift mutated cdaR pseudogene (denoted as 873 
cdaR') in MG1363.  The GlmM I154F mutation in OR5 is shown with an arrow. (E) Levels of 874 
peptidoglycan precursor UDP-N-acetylglucosamine in strains. *, P<0.05 and **, P<0.01 using 875 
Tukey’s test based on triplicate cultures. 876 
 877 
Figure 4. 878 
Autolysis is affected by the c-di-AMP level in cells. Wild-type MG1363 (solid grey line), a high 879 
c-di-AMP containing osmosensitive gdpP mutant (OS2 [solid black line]), and several low c-di-880 
AMP osmoresistant suppressor mutants derived from OS2 containing cdaA (dashed grey lines) 881 
or glmM (OR5 [dashed black line]) mutations were incubated in GM17 broth at 30°C and 882 
monitored with regular OD600 measurements. Averages and standard deviation error bars are 883 
shown based on three biological replicates. 884 
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 Figure 4. 885 
Autolysis is affected by the c-di-AMP level in cells. Wild-type MG1363 (solid black line), a high 886 
c-di-AMP containing osmosensitive gdpP mutant (OS2 [solid grey line]), and several low c-di-887 
AMP osmoresistant suppressor mutants containing cdaA (dashed grey lines) or glmM (OR5 888 
[dashed black line]) mutations were incubated in GM17 broth at 30°C and monitored with 889 
regular OD600 measurements. The experiment was carried out in duplicate (SD is shown as error 890 
bars). 891 
 892 
Figure 5. 893 
GlmM reduces c-di-AMP synthesis by CdaA and the GlmM
I154F 
variant shows greater inhibitory 894 
action. (A) Three different combinations of CdaA operon genes from L. lactis MG1363 were 895 
expressed in E. coli and c-di-AMP levels from three biological replicates were determined.  896 
CdaR' indicates the product(s) from the frameshift mutated cdaR' pseudogene which has 897 
homology to the YbbR domain containing protein CdaR in other bacteria.  The star indicates the 898 
I154F mutation in GlmM. (B) Three different combinations of CdaA operon genes from S. 899 
aureus NCTC 8325 were expressed in E. coli and c-di-AMP levels from three biological 900 
replicates were determined. Significant P<0.01 (**) results were determined using Tukey’s test.  901 
 Figure 5. 902 
GlmM
I154F
 reduces c-di-AMP synthesis by CdaAR' in E. coli more than wild-type GlmM. (A) 903 
Three different combinations of CdaA operon genes from L. lactis MG1363 were expressed in E. 904 
coli.  CdaR' indicates the product(s) from the frameshift mutated cdaR' pseudogene which has 905 
homology to the YbbR domain containing protein CdaR in other bacteria. (B) Levels of c-di-906 
AMP in three E. coli strains expressing genes shown in (A) were determined **, P<0.01 using 907 
Tukey’s test based on triplicate cultures. 908 
 909 
Figure 6. 910 
L. lactis GlmM
I154F
 binds more strongly to CdaA than GlmM. Bacterial two-hybrid analysis 911 
showing β-galactosidase activity in E. coli strains containing different combinations of two 912 
plasmids encoding domains of the B. pertussis adenylate cyclase. Different genes cloned into 913 
pKNT25 or pKT25 and pUT18C are indicated. The leucine zipper GCN4 (Zip) proteins are 914 
positive controls (
a
note that zip in cloned in pKT25 while cdaA was cloned in pKNT25), while 915 
negative controls containing at least one empty plasmid (indicated as ‘―’) are shown. The 916 
negative control strain which had the highest β-galactosidase activity was used for comparison to 917 
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the strain expressing both CdaA and GlmM. Significant P<0.01 (**) results were determined 918 
using Tukey’s test using three biological replicates.  919 
 920 
Figure 7. 921 
Model of the c-di-AMP signalling pathway involving CdaA from results obtained in this and 922 
other studies.  Solid black lines indicate enzymatic reactions, dashed black lines indicate a 923 
translation product, red lines indicate a negative effect and green arrows indicate a positive 924 
effect. Synthesis and degradation of c-di-AMP is carried out by diadenylate cyclase (CdaA as the 925 
most common and is shown here) and phosphodiesterase (GdpP is the most common and is 926 
shown here).  CdaR binds to and regulates CdaA mediated c-di-AMP synthesis (note that in L. 927 
lactis MG1363 cdaR is a pseudogene).  The stringent response nucleotide (p)ppGpp inhibits 928 
GdpP thereby reducing c-di-AMP hydrolysis while high or low c-di-AMP levels can result in an 929 
increase in the (p)ppGpp level.  GlmM binds directly to and inhibits CdaA mediated c-di-AMP 930 
synthesis and c-di-AMP levels affect peptidoglycan precursor (UDP-NAG) biosynthesis, most 931 
likely via GlmM.   932 
 933 
 934 
Figure 6. 935 
Model of the c-di-AMP signalling pathway involving CdaA from results obtained in this and 936 
other studies.  Solid black lines indicate enzymatic reactions, dashed black lines indicate a 937 
translation product, red lines indicate a negative effect and green arrows indicate a positive 938 
effect. Synthesis and degradation of c-di-AMP is carried out by diadenylate cyclase (CdaA as the 939 
most common and is shown here) and phosphodiesterase (GdpP is the most common and is 940 
shown here) enzymes.  CdaR binds to and stimulates CdaA mediated c-di-AMP synthesis (note 941 
that in L. lactis MG1363 cdaR is a pseudogene).  The stringent response nucleotide (p)ppGpp 942 
inhibits GdpP thereby reducing c-di-AMP hydrolysis while high c-di-AMP levels result in an 943 
increase in the (p)ppGpp level.  GlmM inhibits CdaA mediated c-di-AMP synthesis and c-di-944 
AMP levels affect peptidoglycan precursor (UDP-NAG) biosynthesis, most likely via GlmM. 945 
 946 
Supplementary Figure 1.  947 
Alignment of CdaA homologs in Gram-positive bacteria. Darker red shading indicates highly 948 
conserved residues while darker blue shading indicates less conserved residues. The location of 949 
the mutations found in suppressor mutant strains here are indicated by spots above the amino 950 
Formatted: Justified, Space After:  0
pt
Formatted: Font: Not Bold
33 
 
acid. Bacteria listed are as follows: llm, Lactococcus lactis subsp. cremoris MG1363; bce, 951 
Bacillus cereus ATCC 14579; bsu, Bacillus subtilis subsp. subtilis 168; btk, Bacillus 952 
thuringiensis 97-27; cac, Clostridium acetobutylicum ATCC 824; cpe, Clostridium perfringens 953 
13; efa, Enterococcus faecalis V583; gka, Geobacillus kaustophilus; hhd, Halobacillus 954 
halophilus; lac, Lactobacillus acidophilus NCFM; lca, Lactobacillus casei ATCC 334; ljo, 955 
Lactobacillus johnsonii NCC 533; lla, Lactococcus lactis subsp. lactis Il1403; llc, Lactococcus 956 
lactis subsp. cremoris SK11; lme, Leuconostoc mesenteroides subsp. mesenteroides ATCC 957 
8293; lmo, Listeria monocytogenes EGD-e; lpl, Lactobacillus plantarum WCFS1; lrh, 958 
Lactobacillus rhamnosus GG; lsa, Lactobacillus sakei; ooe, Oenococcus oeni; ppe, Pediococcus 959 
pentosaceus ATCC 25745; sav, Staphylococcus aureus subsp. aureus Mu50 (MRSA/VISA); 960 
spm, Streptococcus pyogenes MGAS8232 (serotype M18); spn, Streptococcus pneumoniae 961 
TIGR4 (virulent serotype 4); spy, Streptococcus pyogenes SF370 (serotype M1); stc, 962 
Streptococcus thermophilus CNRZ1066. 963 
